All Posts
Review | Diagnosing delirium in perioperative and intensive care medicine
3 Aug, 2023 | 13:09h | UTCDiagnosing delirium in perioperative and intensive care medicine – Current Opinion in Anesthesiology
Review | Atypical hyperplasia of the breast: Clinical cases and management strategies
3 Aug, 2023 | 13:07h | UTC
WHO | Seven out of 10 people protected by at least one tobacco control measure
2 Aug, 2023 | 14:14h | UTCNews Release: Seven out of 10 people protected by at least one tobacco control measure – World Health Organization
See also: MPOWER measures
Commentaries:
Expert reaction to WHO report on the global tobacco epidemic 2023 – Science Media Centre
Commentary on Twitter
The MPOWER measures include?
?-onitoring tobacco use
?-rotecting people from tobacco smoke
?-ffering support to quit smoking
?-arning about the dangers of tobacco
?-nforcing tobacco advertising, promotion & sponsorship bans
?-aising taxes on TobaccoLearn more.… pic.twitter.com/ImfGsL8in1
— World Health Organization (WHO) (@WHO) July 31, 2023
USPSTF Draft Statement | Insufficient evidence for screening children under 5 years for speech and language delay
2 Aug, 2023 | 14:13h | UTCSpeech and Language Delay and Disorders in Children: Screening – U.S. Preventive Services Task Force
Commentary:
USPSTF: Evidence Lacking for Screening for Speech Delays in Young Children – HealthDay
Perspective | The most important trial in modern cardiology (Critical appraisal of the ISCHEMIA trial)
2 Aug, 2023 | 14:11h | UTCChapter 3: The Most Important Trial in Modern Cardiology – Sensible Medicine
See also:
Chapter 1: What Does it Mean to Discover a Coronary Blockage? – By Dr John Mandrola
Chapter 2: On the meaning of a coronary blockage – By Dr John Mandrola
Related/Original Articles:
ISCHEMIA Trial: Initial Invasive vs. Conservative Strategy for Stable Coronary Disease
ISCHEMIA Trial: Management of Coronary Disease in Patients with Advanced Kidney Disease
Meta-analysis | Even low levels of alcohol consumption may increase blood pressure
2 Aug, 2023 | 14:07h | UTCNews Release: Routinely drinking alcohol may raise blood pressure even in adults without hypertension – AHA Newsroom
Evidence Review | AA and other 12-step programs outperform CBT for alcohol use disorder
2 Aug, 2023 | 14:05h | UTCAlcohol dependence: evidence and experience on 12 steps to recovery – Evidently Cochrane
Original study: Alcoholics Anonymous and other 12‐step programs for alcohol use disorder – Cochrane Library
Guideline on multimodal rehabilitation for patients with post-intensive care syndrome
2 Aug, 2023 | 14:04h | UTC
Commentary from the author on Twitter
Very proud to announce our new publication:
Guideline on multimodal rehabilitation for patients with post-intensive care syndrome
Incl. 1 statement, 12 recommendations, and 4 therapy options for prevention & rehab of patients with PICShttps://t.co/NbjIx7zcwR pic.twitter.com/X63epI7ec7
— Peter Nydahl (@NydahlPeter) July 31, 2023
2023 ACR/EULAR classification criteria for calcium pyrophosphate deposition disease
2 Aug, 2023 | 14:02h | UTCCommentary: 2023 ACR/EULAR Criteria for Calcium Pyrophosphate Deposition Disease – RheumNow
BSH guideline for anticoagulant management of pregnant individuals with mechanical heart valves
2 Aug, 2023 | 14:01h | UTC
RCT | Multiple sclerosis disease-modifying therapy continuation versus discontinuation in older individuals
2 Aug, 2023 | 14:00h | UTCRisk of new disease activity in patients with multiple sclerosis who continue or discontinue disease-modifying therapies (DISCOMS): a multicentre, randomised, single-blind, phase 4, non-inferiority trial – The Lancet Neurology (link to abstract – $ for full-text)
Commentaries:
Discontinuing Multiple Sclerosis Therapies at Age 55 or Older – NEJM Journal Watch
Debate | Do all patients with asymptomatic severe aortic stenosis need valve replacement?
2 Aug, 2023 | 13:58h | UTC
Commentary on Twitter
Great debate just published in #EHJ: all patients with asymptomatic severe aortic stenosis need valve replacement.https://t.co/2BclgoYvKj#aorticstenosis @escardio @ESC_Journals pic.twitter.com/Qslzw6EiCa
— EHJ Editor-in-Chief (@ehj_ed) August 1, 2023
RCT | Atogepant outperforms placebo in reducing migraines over 12 weeks
2 Aug, 2023 | 13:56h | UTCAtogepant for the preventive treatment of chronic migraine (PROGRESS): a randomised, double-blind, placebo-controlled, phase 3 trial – The Lancet (link to abstract – $ for full-text)
RCT | Lazertinib offers 20.6-month of median PFS in EGFR-mutated NSCLC vs 9.7 months with gefitinib
2 Aug, 2023 | 13:55h | UTC
RCT | Camrelizumab-rivoceranib outperforms sorafenib as first-line therapy for unresectable HCC
2 Aug, 2023 | 13:53h | UTCCamrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): a randomised, open-label, international phase 3 study – The Lancet (link to abstract – $ for full-text)
Commentary on Twitter
New @TheLancet – Qin et al – Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): a randomised, open-label, international phase 3 studyhttps://t.co/YoutfY5IkA#LiverTwitter #OncTwitter #LiverCancer #HCC pic.twitter.com/Tcvm6D3kCW
— The Lancet Gastroenterology & Hepatology (@LancetGastroHep) July 25, 2023
Case Report | Post-myocardial infarction free-wall rupture: rapid diagnosis and management
2 Aug, 2023 | 13:52h | UTCPost-Myocardial Infarction Free-Wall Rupture: Rapid Diagnosis and Management – JACC: Case Reports
Commentary on Twitter
Learn how to evaluate, diagnose and manage #cvMI wall rupture to improve survival in #JACCCaseReports' latest issue: https://t.co/aGPJ1rZ8eu#CardioTwitter #cvSurg #CathLab pic.twitter.com/bPTtJownNf
— JACC Journals (@JACCJournals) July 31, 2023
M-A | High-volume disease, T stage 4 show largest docetaxel benefit in prostate cancer
2 Aug, 2023 | 13:51h | UTCCommentaries:
Disease Volume and T Stage Affect Docetaxel/ADT Efficacy in Prostate Cancer – Cancer Network
Commentary on Twitter
NEW: A systematic review and meta-analysis of individual patient data from the STOPCAP M1 collaboration aims to obtain up-to-date estimates of the effects of docetaxel in patients with metastatic hormone-sensitive prostate cancer. #pcsmhttps://t.co/7mqXeIXMQ5 pic.twitter.com/A7AmjipnVq
— The Lancet Oncology (@TheLancetOncol) July 5, 2023
Cohort Study | Depression at any life stage linked to increased dementia incidence
2 Aug, 2023 | 13:49h | UTCAssociation of Early-, Middle-, and Late-Life Depression With Incident Dementia in a Danish Cohort – JAMA Neurology (link to abstract – $ for full-text)
Commentary: Depression Over Adulthood May Increase Risk of Dementia – Psychiatric News Alert
RCT | Maternal egg intake in early neonatal period does not impact infant egg allergy risk
2 Aug, 2023 | 13:47h | UTCSee also: Visual Abstract
RCT | Baricitinib demonstrates efficacy in treatment-resistant juvenile idiopathic arthritis
2 Aug, 2023 | 13:45h | UTCBaricitinib in juvenile idiopathic arthritis: an international, phase 3, randomised, double-blind, placebo-controlled, withdrawal, efficacy, and safety trial – The Lancet (link to abstract – $ for full-text)
Commentary on Twitter
NEW in @TheLancet—Baricitinib was efficacious with an acceptable safety profile in patients with #juvenile idiopathic #arthritis in a phase 3 withdrawal trialhttps://t.co/vZyXUwBiDZ #JIA
Plus linked Comment: https://t.co/VWofLvL427 pic.twitter.com/MGVoUz4xIv
— The Lancet Rheumatology (@TheLancetRheum) July 10, 2023
RCT | Platelet-rich plasma injections lack efficacy in 52-week ankle osteoarthritis study
2 Aug, 2023 | 13:43h | UTC
RCT | Early vs. delayed intrauterine balloon tamponade: no difference in severe postpartum hemorrhage
2 Aug, 2023 | 13:42h | UTCEfficacy of early intrauterine balloon tamponade for immediate postpartum hemorrhage after vaginal delivery: a randomized clinical trial – The American Journal of Obstetrics and Gynecology (link to abstract – $ for full-text)
Consensus Paper | Diagnosis and management of infective endocarditis in adults
1 Aug, 2023 | 14:34h | UTC
Review | Futility in clinical trials
1 Aug, 2023 | 14:32h | UTCFutility in Clinical Trials – JAMA (free for a limited period)
Study | AI use in lung cancer screening enhances prediction of lung cancer death, CVD death, and all-cause death
1 Aug, 2023 | 14:31h | UTCAI Body Composition in Lung Cancer Screening: Added Value Beyond Lung Cancer Detection – Radiology (free for a limited period)
Commentary: Study: AI Assessment of Chest CT May Predict Multiple Mortality Risks – Diagnostic Imaging